🇺🇸 FDA
Patent

US 10441586

CRMP2 SUMOylation inhibitors and uses thereof

granted A61KA61K31/452A61K31/4525

Quick answer

US patent 10441586 (CRMP2 SUMOylation inhibitors and uses thereof) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents on Behalf of the University of Arizona
Grant date
Tue Oct 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/452, A61K31/4525, A61K31/495, A61K31/496